Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hannah Staats"'
Autor:
Mamtha Balla, Hannah Staats-Ciotola, Meera Dhavale, Vikram Sangani, Mytri Pokal, Ganesh Prasad Merugu, Venu Madhav Konala, Sreedhar Adapa, Srikanth Naramala, Sai Sri Harsha Rallabhandi
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives. 12:94-99
Autor:
John Nemunaitis, Monika Devanaboyina, Nealie Ngo, Rakan Albalawy, Louis Filipiak, Hannah Staats, Laura Stanbery, Danae Hamouda
Publikováno v:
Clinical Oncology and Research. :1-13
Angiogenesis plays an important role in tumor growth. Established vasculature provides a supply of nutrients and other necessary survival factors for tumor cell maintenance. In addition, immune factors with capacity to both decrease immune activity l
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 6532, p 6532 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Ovarian cancer response to immunotherapy is limited; however, the evaluation of sensitive/resistant target treatment subpopulations based on stratification by tumor biomarkers may improve the predictiveness of response to immunotherapy. These markers
Autor:
Katelyn R. Einloth, Hannah Staats, Luisa Manning, Adam Walter, Phylicia Aaron, John Nemunaitis, Danielle Dever, Lance D. Dworkin, Laura Stanbery, Vinaya Gogineni, Susan Morand, Monika Devanaboyina, Rachel Royfman, Gerald Edelman
Publikováno v:
Journal of Cancer
While ovarian cancer typically responds well to front line treatment, many patients will relapse within 5 years. Treatment options are less effective at each recurrence highlighting the need for novel maintenance therapies. PolyADP-ribose polymerase
Autor:
Laura Stanbery, Hannah Staats, John Nemunaitis, Susan Morand, Bashar Kahaleh, Azwar K. Iqbal, Justin F. Creeden, Lance D. Dworkin
Publikováno v:
Future oncology (London, England). 16(9)
Given recent advances in cancer immune therapy, specifically use of checkpoint inhibitors, understanding the link between autoimmunity and cancer is essential. Rheumatoid arthritis (RA) affects about 1% of the population, and early diagnosis is key t
Autor:
John Nemunaitis, Amanda Lenhard, F. Charles Brunicardi, Hannah Staats, Christine S Cassidy, Mary T Albrethsen, Jesse D Kelso, Khalil Choucair, Joseph R Duff, Rayna Patel, Lance D. Dworkin
Publikováno v:
Future oncology (London, England). 15(26)
Natural killer (NK) cells lead immune surveillance against cancer and early elimination of small tumors. Owing to their ability to engage tumor targets without the need of specific antigen, the therapeutic potential of NK cells has been extensively e